Unión Europea -
danés -
EMA (European Medicines Agency)
ultomiris
alexion europe sas - ravulizumab - hemoglobinuri, paroxysmal - selektive immunosuppressiva - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
crestor 10 mg filmovertrukne tabletter
abacus medicine a/s - rosuvastatin calcium - filmovertrukne tabletter - 10 mg
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
nexium 10 mg enterogranulat til oral suspension
2care4 aps - esomeprazolemagnesiumtrihydrat - enterogranulat til oral suspension - 10 mg
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxis turbuhaler 4,5 mikrogram/dosis inhalationspulver
2care4 aps - formoterolfumarat dihydrat - inhalationspulver - 4,5 mikrogram/dosis
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxis turbuhaler 9 mikrogram/dosis inhalationspulver
2care4 aps - formoterolfumarat dihydrat - inhalationspulver - 9 mikrogram/dosis
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
pulmicort turbohaler 400 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 400 mikrogram/dosis
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
pulmicort turbuhaler 100 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 100 mikrogram/dosis
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
pulmicort turbuhaler 200 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 200 mikrogram/dosis
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
pulmicort turbuhaler 400 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 400 mikrogram/dosis
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
symbicort 4,5+160 mikrog/dosis inhalationsspray, suspension
2care4 aps - budesonid, formoterolfumarat dihydrat - inhalationsspray, suspension - 4,5+160 mikrog/dosis